Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-07-31
1991-08-20
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514927, 544349, 548532, 548539, 548540, 548537, 548561, 548562, A61K 31495, C07D48704, C07D207333, C07D20734
Patent
active
050414429
ABSTRACT:
This invention is directed to compounds of formula (I): ##STR1## wherein R.sup.1 is thiocyano, --CH.sub.2 CN, --NH.sub.2, --NHR.sup.5, or --CH.sub.2 OR.sup.5 where R.sup.5 is lower alkyl;
REFERENCES:
patent: 4450164 (1984-05-01), Bristol
patent: 4507294 (1985-03-01), Bristol
Peresada Khim.-Farm. Zh. 1987, vol. 21, No. 9, pp. 1054-1059 (English Translation Provided).
Kaminski J. Med. Chem., 1987, vol. 30, pp. 2031-2046.
J. Med. Chem., 1987, vol. 30, pp. 2047-2051.
Castaneda Armando C.
Franco Fidencio
Muchowski Joseph M.
Romero Ruth S.
Berch Mark L.
Freyberg Derek P.
Moran Tom M.
Roth Carol J.
Syntex (U.S.A.) Inc.
LandOfFree
Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1008177